References
- AcerbiAParisiDThe evolution of painCostaFARochaLMCostaEHarveyICoutinhoAAdvances in Artificial LifeECAL 2007: Proceedings of the 9th Annual Conference on Advances in Artificial LifeSeptember 10–14, 2007Lisbon, PortugalBerlinSpringer2007816824
- LoeserJDMelzackRPain: an overviewLancet199935391641607106910334273
- BreivikHPain managementBaillieres Clin Anaesthesiol199484775795
- KoppertWSchmelzMThe impact of opioid-induced hyperalgesia for postoperative painBest Pract Res Clin Anaesthesiol2007211658317489220
- ChauDLWalkerVPaiLChoLMOpiates and elderly: use and side effectsClin Interv Aging20083227327818686750
- BuvanendranAKroinJSMultimodal analgesia for controlling acute postoperative painCurr Opin Anaesthesiol200922558859319606021
- DahlVRaederJCNon-opioid postoperative analgesiaActa Anaesthesiol Scand200044101191120311065198
- TuncerSAysolmazGReisliRErolAYalçinNYosunkayaAThe effects of the administration of subfacial levobupivacaine infusion with the ON-Q pain pump system on postoperative analgesia and tramadol consumption in cesarean operationsAgri2010222737820582749
- BorgeatAEkatodramisGAnaesthesia for shoulder surgeryBest Pract Res Clin Anaesthesiol200216221122512491553
- OsadaRZukawaMSekiEKimuraTContinuous peripheral nerve block in forearm for severe hand traumaHand Surg201116323924422072454
- ChellyJEDelaunayLWilliamsBBorghiBOutpatient lower extremity infusionsBest Pract Res Clin Anaesthesiol200216231132012491560
- RichmanJMLiuSSCourpasGDoes continuous peripheral nerve block provide superior pain control to opioids? A meta-analysisAnesth Analg2006102124825716368838
- ChellyJEGhisiDFanelliAContinuous peripheral nerve blocks in acute pain managementBr J Anaesth2010105Suppl 1i86i9621148658
- MantripragadaSA lipid based depot (DepoFoam technology) for sustained release drug deliveryProg Lipid Res200241539240612121719
- NewRRCInfluence of liposome characteristics on their properties and fatePhilippotJRSchuberFLiposomes as Tools in Basic Research and IndustryBoca RatonCRC Press1995320
- MowatJJMokMJMacLeodBAMaddenTDLiposomal bupivacaine. Extended duration nerve blockade using large unilamellar vesicles that exhibit a proton gradientAnesthesiology19968536356438853095
- OstroMJCullisPRUse of liposomes as injectable-drug delivery systemsAm J Hosp Pharm1989468157615872672806
- RichardBMOttLRHaanDThe safety and tolerability evaluation of DepoFoam bupivacaine (bupivacaine extended-release liposome injection) administered by incision wound infiltration in rabbits and dogsExpert Opin Investig Drugs2011201013271341
- RichardBMNewtonPOttLRThe safety of EXPAREL® (bupivacaine liposome injectable suspension) administered by peripheral nerve block in rabbits and dogsJ Drug Deliv [Serial on the Internet]12012 [cited July 2, 2012];962101:[10 p.]. http://www.hindawi.com/journals/jdd/2012/962101/Accessed July 2, 2012
- DullenkopfABorgeatALocal anesthetics. Differences and similarities in the “-cains”Anaesthesist200352432934012715136
- CovinoBGPharmacology of local anaesthetic agentsBr J Anaesth19865877017162425835
- DavidsonEMBarenholzYCohenRHaroutiunianSKaganLGinosarYHigh-dose bupivacaine remotely loaded into multivesicular liposomes demonstrates slow drug release without systemic toxic plasma concentrations after subcutaneous administration in humansAnesth Analg201011041018102320357145
- LangfordRMChappellGMKarraschJAA single administration of DepoBupivacaine (TM) intraoperatively results in prolonged detectable plasma bupivacaine and analgesia in patients undergoing inguinal hernia repairPoster presented at: 62nd Annual Postgraduate Assembly of the New York State Society of AnesthesiologistsDecember 12–16, 2008New York, NY
- GantenbeinMAttoliniLBruguerolleBOxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3ADrug Metab Dispos200028438338510725304
- OnelEWarnottKLambertWPatouGPharmacokinetics of depobupivacaine (EXPAREL™), a novel bupivacaine extended release liposomal injection, in volunteers with moderate hepatic impairmentPoster presented at: 112th Annual Meeting of the American Society of Clinical Pharmacology and TherapeuticsMarch 3–6, 2011Dallas, TX
- US Food and Drug AdministrationFDA Label Approved on 10/28/2011 (PDF) for EXPARELUS Silver Spring, MDUS Food and Drug Administration Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022496s000lbl.pdfAccessed May 01, 2012
- GorfineSROnelEPatouGKrivokapicZVBupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trialDis Colon Rectum201154121552155922067185
- GolfMDanielsSEOnelEA phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomyAdv Ther201128977678821842428
- SmootJDBergeseSDOnelEWilliamsHTHeddenWThe efficacy and safety of DepoFoam bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammoplasty: a randomized, double-blind, active-control studyAesthet Surg J2012321697622179931
- BramlettKOnelEViscusiERJonesKA randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplastyKneeIn press1272012
- BoogaertsJGLafontNDDeclercqAGEpidural administration of liposome-associated bupivacaine for the management of postsurgical pain: a first studyJ Clin Anesth1994643153207946368
- AstraZeneca CanadaBupivacaine Prescribing InformationMississauga, ONAstraZeneca Canada Inc Available from: http://www.astrazeneca.ca/documents/ProductPortfolio/SENSORCAINE_PM_en.pdfAccessed April 28, 2012
- TuckerGTMatherLEClinical pharmacokinetics of local anaestheticsClin Pharmacokinet197944241278385208
- WolfeJWButterworthJFLocal anesthetic systemic toxicity: update on mechanisms and treatmentCurr Opin Anaesthesiol201124556156621841477
- YangSAbrahamsMSHurnPDGrafeMRKirschJRLocal anesthetic Schwann cell toxicity is time and concentration dependentReg Anesth Pain Med201136544445121857272
- ZinkWGrafBMLocal anesthetic myotoxicityReg Anesth Pain Med200429433334015305253
- Gómez-ArnauJIYangüelaJGonzálezAAnaesthesia-related diplopia after cataract surgeryBr J Anaesth200390218919312538376
- VlăduţiuCSevanSCiuicăMDiplopia through toxic myopathy after cataract surgeryOftalmologia20085247782
- BergeseSDOnelEMorrenMMorganrothJBupivacaine extended-release liposome injection exhibits a favorable cardiac safety profileReg Anesth Pain Med201237214515122266897
- NaseemAHaradaTWangDBupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteersJ Clin Pharmacol Epub November 4, 2011
- MinkowitzHSOnelEPatronellaCKSmootJDA two-year observational study assessing the safety of DepoFoam bupivacaine after augmentation mammaplastyAesthet Surg J201232218619322238339
- PintoLMPereiraRde PaulaEde NucciGSantanaMHDonatoJLInfluence of liposomal local anesthetics on platelet aggregation in vitroJ Liposome Res2004141–2515915461932
- Pacira Pharmaceuticals Inc.Exparel (Bupivacaine Liposome Injectable Suspension) Product MonographParsippany, NJPacira Pharmaceuticals, Inc Available from: http://www.exparel.com/pdf/Exparel_Monograph.pdfAccessed May 01, 2012